| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |